NantKwest Names Fatih M. Uckun, M.D., Vice President Of Research And Clinical Development

CULVER CITY, Calif.--(BUSINESS WIRE)--NantKwest, Inc. (Nasdaq: NK), a clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using natural killer cells to treat cancer, infectious diseases and inflammatory diseases, today announced the appointment of Fatih M. Uckun, M.D., as vice president of research and clinical development. Dr. Uckun will be responsible for spearheading the company’s overall scientific development strategy, including management of the pipeline and clinical development programs.